Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000362894 | SCV000387701 | uncertain significance | Elliptocytosis | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000270638 | SCV000387702 | uncertain significance | Spherocytosis, Dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003565403 | SCV004324888 | benign | not provided | 2023-08-24 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV003565403 | SCV004564111 | likely benign | not provided | 2023-05-26 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV003565403 | SCV005191411 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003930343 | SCV004739006 | benign | SPTB-related disorder | 2019-05-23 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |